for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Fleury SA

FLRY3.SA

Latest Trade

24.74BRL

Change

-0.26(-1.04%)

Volume

1,201,100

Today's Range

24.60

 - 

25.00

52 Week Range

18.71

 - 

26.45

As of on the Bolsa de Valores do Estado de Sao Paulo ∙ Minimum 15 minute delay

Pricing

Previous Close
25.00
Open
24.99
Volume
1,201,100
3M AVG Volume
36.65
Today's High
25.00
Today's Low
24.60
52 Week High
26.45
52 Week Low
18.71
Shares Out (MIL)
316.74
Market Cap (MIL)
7,836.26
Forward P/E
21.99
Dividend (Yield %)
3.70

Next Event

Q3 2019 Fleury SA Earnings Release

Latest Developments

More

Shares In Brazil's medical labs co Fleury rise 1.2 pct After Acquisitions Announcements

Fleury SA proposes dividend payment

Fleury SA announces changes in shareholding structure

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Fleury SA

Fleury SA, formerly Laboratorio de Analises e Pesquisas Clinicas SC Ltda, is a Brazil-based company engaged in the provision of medical laboratory services. The Company’s activities are divided into three business segments: Diagnostic medicine, Integrated medicine and Dental. The Diagnostic medicine division provides clinical analysis and diagnostic imaging in partner hospitals. The Integrated medicine division offers private medical diagnostics, as well as tests for laboratories, hospitals and clinics. The Dental division focuses on dental diagnostic imaging. The Company provides services in Brazil through a number of brand names, such as Fleury, Felippe Mattoso, Weinmann, a+ Medicina Diagnostica, Labs a+, Diagnoson a+ and Papaiz.

Industry

Healthcare Facilities

Contact Info

Av. General Valdomiro de Lima, 508

+55.11.50147413

http://www.fleury.com.br/

Executive Leadership

Marcos Bosi Ferraz

Chairman of the Board

Marcio Pinheiro Mendes

Chairman of the Board

Carlos Alberto Iwata Marinelli

Chief Executive Officer

Fernando Lopes Alberto

Vice Chairman of the Board

Fernando Augusto Rodrigues Leao

Chief Financial, Investor Relations and Legal Officer

Key Stats

2.70 mean rating - 10 analysts
Sell
Hold
Buy
Revenue (MM, BRL)

2016

2.1K

2017

2.4K

2018

2.7K

2019(E)

2.9K
EPS (BRL)

2016

0.718

2017

0.990

2018

1.030

2019(E)

1.125
Price To Earnings (TTM)
25.28
Price To Sales (TTM)
2.83
Price To Book (MRQ)
4.59
Price To Cash Flow (TTM)
13.45
Total Debt To Equity (MRQ)
122.22
LT Debt To Equity (MRQ)
103.25
Return on Investment (TTM)
8.72
Return on Equity (TTM)
7.35

Latest News

Latest News

BRIEF-Brazil's Fleury agrees to buy Instituto de Radiologia de Natal

* BRAZIL'S FLEURY AGREES TO BUY INSTITUTO DE RADIOLOGIA DE NATAL AT APPRAISED VALUE OF 90.5 MILLION REAIS -FILING Source text in Portuguese: [http://bit.ly/2GV7w98] Further company coverage: (Reporting By Jake Spring)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up